Cancer-specific gene carriers responding to cancer microenvironment: Acidosis and hyper-activated protein kinases

Satoshi Kushio, Akira Tsuchiya, Yuta Nakamura, Takanobu Nobori, Chan Woo Kim, Guo Xi Zhao, Taiki Funamoto, Eun Kyung Lee, Takuro Niidome, Takeshi Mori, Yoshiki Katayama

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Protein kinase (PK)-responsive gene carriers modified with polyethylene glycol (PEG) chains using an acid-labile linker were developed. These carriers were obtained by modifying the PEG chains and substrate peptides for the PKs (PKA or PKCα) on the branched polyethyleneimine main chain. Polyplexes formed from these carriers and plasmid DNA (pDNA) were stably dispersed under neutral pH medium. The polyplexes were also taken up by cells on the release of the PEG chains under the slightly acidic extracellular pH associated with cancer cells. The polyplexes taken up by cells resulted in gene expression when the substrate peptides were phosphorylated by the intracellular PKs to release pDNA from the polyplexes. These novel gene carriers are expected to be promising for cancer-specific gene therapy via intravenous administration.

Original languageEnglish
Article number1340005
JournalBiomedical Engineering - Applications, Basis and Communications
Volume25
Issue number5
DOIs
Publication statusPublished - Oct 1 2013

Fingerprint

Tumor Microenvironment
Neoplasm Genes
Acidosis
Protein Kinases
Polyethylene glycols
Genes
Proteins
Peptides
Plasmids
DNA
Polyethyleneimine
Gene therapy
Substrates
Gene expression
Intravenous Administration
Genetic Therapy
Cells
Gene Expression
Acids
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomedical Engineering

Cite this

Cancer-specific gene carriers responding to cancer microenvironment : Acidosis and hyper-activated protein kinases. / Kushio, Satoshi; Tsuchiya, Akira; Nakamura, Yuta; Nobori, Takanobu; Kim, Chan Woo; Zhao, Guo Xi; Funamoto, Taiki; Lee, Eun Kyung; Niidome, Takuro; Mori, Takeshi; Katayama, Yoshiki.

In: Biomedical Engineering - Applications, Basis and Communications, Vol. 25, No. 5, 1340005, 01.10.2013.

Research output: Contribution to journalArticle

Kushio, Satoshi ; Tsuchiya, Akira ; Nakamura, Yuta ; Nobori, Takanobu ; Kim, Chan Woo ; Zhao, Guo Xi ; Funamoto, Taiki ; Lee, Eun Kyung ; Niidome, Takuro ; Mori, Takeshi ; Katayama, Yoshiki. / Cancer-specific gene carriers responding to cancer microenvironment : Acidosis and hyper-activated protein kinases. In: Biomedical Engineering - Applications, Basis and Communications. 2013 ; Vol. 25, No. 5.
@article{9998bd15a6124d20b45ceb16e1f2a016,
title = "Cancer-specific gene carriers responding to cancer microenvironment: Acidosis and hyper-activated protein kinases",
abstract = "Protein kinase (PK)-responsive gene carriers modified with polyethylene glycol (PEG) chains using an acid-labile linker were developed. These carriers were obtained by modifying the PEG chains and substrate peptides for the PKs (PKA or PKCα) on the branched polyethyleneimine main chain. Polyplexes formed from these carriers and plasmid DNA (pDNA) were stably dispersed under neutral pH medium. The polyplexes were also taken up by cells on the release of the PEG chains under the slightly acidic extracellular pH associated with cancer cells. The polyplexes taken up by cells resulted in gene expression when the substrate peptides were phosphorylated by the intracellular PKs to release pDNA from the polyplexes. These novel gene carriers are expected to be promising for cancer-specific gene therapy via intravenous administration.",
author = "Satoshi Kushio and Akira Tsuchiya and Yuta Nakamura and Takanobu Nobori and Kim, {Chan Woo} and Zhao, {Guo Xi} and Taiki Funamoto and Lee, {Eun Kyung} and Takuro Niidome and Takeshi Mori and Yoshiki Katayama",
year = "2013",
month = "10",
day = "1",
doi = "10.4015/S101623721340005X",
language = "English",
volume = "25",
journal = "Biomedical Engineering - Applications, Basis and Communications",
issn = "1016-2372",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "5",

}

TY - JOUR

T1 - Cancer-specific gene carriers responding to cancer microenvironment

T2 - Acidosis and hyper-activated protein kinases

AU - Kushio, Satoshi

AU - Tsuchiya, Akira

AU - Nakamura, Yuta

AU - Nobori, Takanobu

AU - Kim, Chan Woo

AU - Zhao, Guo Xi

AU - Funamoto, Taiki

AU - Lee, Eun Kyung

AU - Niidome, Takuro

AU - Mori, Takeshi

AU - Katayama, Yoshiki

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Protein kinase (PK)-responsive gene carriers modified with polyethylene glycol (PEG) chains using an acid-labile linker were developed. These carriers were obtained by modifying the PEG chains and substrate peptides for the PKs (PKA or PKCα) on the branched polyethyleneimine main chain. Polyplexes formed from these carriers and plasmid DNA (pDNA) were stably dispersed under neutral pH medium. The polyplexes were also taken up by cells on the release of the PEG chains under the slightly acidic extracellular pH associated with cancer cells. The polyplexes taken up by cells resulted in gene expression when the substrate peptides were phosphorylated by the intracellular PKs to release pDNA from the polyplexes. These novel gene carriers are expected to be promising for cancer-specific gene therapy via intravenous administration.

AB - Protein kinase (PK)-responsive gene carriers modified with polyethylene glycol (PEG) chains using an acid-labile linker were developed. These carriers were obtained by modifying the PEG chains and substrate peptides for the PKs (PKA or PKCα) on the branched polyethyleneimine main chain. Polyplexes formed from these carriers and plasmid DNA (pDNA) were stably dispersed under neutral pH medium. The polyplexes were also taken up by cells on the release of the PEG chains under the slightly acidic extracellular pH associated with cancer cells. The polyplexes taken up by cells resulted in gene expression when the substrate peptides were phosphorylated by the intracellular PKs to release pDNA from the polyplexes. These novel gene carriers are expected to be promising for cancer-specific gene therapy via intravenous administration.

UR - http://www.scopus.com/inward/record.url?scp=84886426056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886426056&partnerID=8YFLogxK

U2 - 10.4015/S101623721340005X

DO - 10.4015/S101623721340005X

M3 - Article

AN - SCOPUS:84886426056

VL - 25

JO - Biomedical Engineering - Applications, Basis and Communications

JF - Biomedical Engineering - Applications, Basis and Communications

SN - 1016-2372

IS - 5

M1 - 1340005

ER -